PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31012983-0	2019	Altered Glycemic Control Associated With Polymorphisms in the SLC22A1 (OCT1) Gene in a Mexican Population With Type 2 Diabetes Mellitus Treated With Metformin: A Cohort Study.	Metformin	149-158	solute carrier family 22 member 1	Homo sapiens	62-69	
31012983-0	2019	Altered Glycemic Control Associated With Polymorphisms in the SLC22A1 (OCT1) Gene in a Mexican Population With Type 2 Diabetes Mellitus Treated With Metformin: A Cohort Study.	Metformin	149-158	solute carrier family 22 member 1	Homo sapiens	71-75	
31012983-1	2019	The organic cation transporters OCT1 and OCT2 and the multidrug and toxin extrusion transporter MATE1, encoded by the SLC22A1, SLC22A2, and SLC47A1 genes, respectively, are responsible for the absorption of metformin in enterocytes, hepatocytes, and kidney cells.	Metformin	207-216	solute carrier family 22 member 1	Homo sapiens	32-36	
31012983-1	2019	The organic cation transporters OCT1 and OCT2 and the multidrug and toxin extrusion transporter MATE1, encoded by the SLC22A1, SLC22A2, and SLC47A1 genes, respectively, are responsible for the absorption of metformin in enterocytes, hepatocytes, and kidney cells.	Metformin	207-216	solute carrier family 22 member 1	Homo sapiens	118-125	
31012983-2	2019	The aim of this study was to evaluate whether genetic variations in the SLC22A1, SLC22A2, and SLC47A1 genes could be associated with an altered response to metformin in patients with type 2 diabetes mellitus.	Metformin	156-165	solute carrier family 22 member 1	Homo sapiens	72-79